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Supplement Figure 1. Thyroid histology of control #213MM and #213MM mice injected with 
Ad-TgP-Cre at 4 weeks of age.  Representative data at 12th and 52nd weeks were shown.   
 
Supplement Figure 2. The lentivirus vectors, V5 expression and H&E histology of the thyroids 
from TPO-Cre mice mock-injected or injected with the lentivirus.   (A) The structures of the 
lentivirus vectors, LEL-BRAFV600E-V5 and LEL-LacZ-V5.  (B) Immunohistochemistry of V5 
expression in the thyroids of TPO-Cre mice mock-injected or injected with the lentivirus.  (C) 
H&E staining of the thyroids of TPO-Cre mice mock-injected or injected with the lentivirus 48 
weeks after injection.. 
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